Intraperitoneal autologous gamma/delta T cell therapy for refractory gastric cancer with ascites.
Not Applicable
- Conditions
- Primary gastric adenocarcinoma
- Registration Number
- JPRN-UMIN000004130
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have: - Pulmonary fibrosis or interstitial pneumonia, including their history or predisposition; - Active enteritis and/or gastrointestinal bleeding; - Active autoimmune diseases; - Active infections; - Other cancers; - Brain metastasis; - Continuous systemic administration of steroids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method